MaxCyte Inc.

NASDAQ: MXCT · Real-Time Price · USD
1.40
0.04 (2.94%)
At close: Aug 18, 2025, 3:59 PM
1.42
1.43%
After-hours: Aug 18, 2025, 06:09 PM EDT

MaxCyte Revenue

MaxCyte reported an annual revenue of $38.63M, reflecting a -6.44% growth. For the quarter ending June 30, 2025, MaxCyte generated $8.51M in revenue.
Revenue (ttm)
38.63M
Revenue Growth
-6.44%
Price / Sales Ratio
11.29
Revenue / Employee
338.83K
Employees
114
Market Cap
149.25M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 38.63M -6.44%
Dec 31, 2023 41.29M -6.72%
Dec 31, 2022 44.26M +30.59%
Dec 31, 2021 33.89M +29.52%
Dec 31, 2020 26.17M +21.04%
Dec 31, 2019 21.62M +29.72%
Dec 31, 2018 16.67M +19.18%
Dec 31, 2017 13.98M +13.98%
Dec 31, 2016 12.27M +32.07%
Dec 31, 2015 9.29M +29.67%
Dec 31, 2014 7.16M +5.28%
Dec 31, 2013 6.8M +34.50%
Dec 31, 2012 5.06M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.